Inspire Investing, LLC Supernus Pharmaceuticals, Inc. Transaction History

Inspire Investing, LLC

13 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2022 Aug 10, 2022	BUY	$25.33 - $34.25 $126 - $171	5 Added 0.07%	7,349 $213,000
Q1 2022 Apr 21, 2022	SELL	$28.51 - $32.9 $29,479 - $34,018	-1,034 Reduced 12.34%	7,344 $237,000
Q4 2021 Feb 14, 2022	BUY	$26.37 - $34.22 $220,927 - $286,695	8,378 New	8,378 $244,000
Q4 2021 Feb 03, 2022	SELL	$26.37 - $34.22 $222,773 - $289,090	-8,448 Closed	0 $0
Q3 2021 Nov 09, 2021	SELL	$23.54 - $31.39 $93,218 - $124,304	-3,960 Reduced 31.91%	8,448 $225,000
Q2 2021 Aug 10, 2021	BUY	$26.72 - $33.19 $10,046 - $12,479	376 Added 3.13%	12,408 $382,000
Q1 2021 Apr 30, 2021	BUY	$24.15 - $31.45 $62,983 - $82,021	2,608 Added 27.67%	12,032 $315,000
Q4 2020 Feb 12, 2021	BUY	$17.7 - $25.81 $166,804 - $243,233	9,424 New	9,424 $237,000
Q3 2020 Nov 16, 2020	SELL	$20.2 - $25.05 $182,850 - $226,752	-9,052 Closed	0 $0
Q2 2020 Aug 12, 2020	SELL	$17.09 - $24.89 $64,531 - $93,984	-3,776 Reduced 29.44%	9,052 $215,000
Q1 2020 May 08, 2020	BUY	$14.45 - $24.69 $185,364 - $316,723	12,828 New	12,828 $231,000
Q1 2018 Apr 13, 2018	SELL	$37.15 - $46.9 $52,975 - $66,879	-1,426 Closed	0 $0
Q4 2017 Feb 15, 2018	BUY	$36.4 - $42.6 $51,906 - $60,747	1,426	1,426 $57,000

282

60.9M

27.7K

11.3K

Ticker SUPN
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 53,495,300
Market Cap $1.94B
Description
Supernus Pharmaceuticals, Inc., a biopharmaceutical company, focuses on the development and commercialization of products for the treatment of central nervous system (CNS) diseases in the United States. Its commercial products are Trokendi XR, an extended release topiramate product indicated for the treatment of epilepsy, as well as for the prop...

Get notified when there are updates to the investment portfolio of Inspire Investing, LLC, based on Form 13F filings with the SEC.

Stay updated on Inspire Investing, LLC with notifications on news.